Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections.

Benjamin AugustAndrew Matlob Pramodini B Kale-Pradhan

Published in: The Annals of pharmacotherapy (2023)

SUL-DUR has shown to be predominantly noninferior to alternative antibiotics in the treatment of pneumonias caused by CRAB, making it a viable treatment option. Further postmarketing data is needed to ascertain its role in other infections.

Keyphrases

acinetobacter baumannii
drug resistant
multidrug resistant
combination therapy
cystic fibrosis
big data
artificial intelligence
deep learning
smoking cessation